# Embark Veterinary

> Embark Veterinary sells at-home dog DNA tests for breed ancestry, relatives, traits and genetic health risks, alongside age and gut health tests and supplements. Founded in 2015, the Boston company pairs canine genetic data with volunteered owner surveys to support research and develop new health insights for pet owners, breeders and veterinarians.

- **Founded:** 2015
- **Headquarters:** Boston, United States
- **Founders:** Ryan Boyko (Co-founder; founding CEO), Adam Boyko (Co-founder; canine geneticist and Cornell professor), Spencer Wells (Co-founder; geneticist), Matt Salzberg (Co-founder)
- **Products:** Breed + Health Dog DNA Test, Embark for Breeders, Breed ID Dog DNA Test, Purebred Dog DNA Test, Embark for Veterinarians
- **Notable:** Reports three million dogs tested on its current milestone page., Published a 2018 PLOS Genetics study using 6,000 dogs that identified a duplication near ALX4 associated with blue eyes., Raised a US$75 million Series B in July 2021.

## Products & services

- **Breed + Health Dog DNA Test** — Breed ancestry, DNA relatives, physical traits, inbreeding information and screening for 270+ genetic health conditions; current science page lists 400+ breeds.
- **Embark for Breeders** — Genetic health, carrier and diversity testing with breeder tools and services.
- **Breed ID Dog DNA Test** — Breed composition, ancestry and DNA relatives without the full health panel.
- **Purebred Dog DNA Test** — Ancestry and health screening for purebred pet dogs.
- **Embark for Veterinarians** — Genetic screening and veterinary reporting workflows.
- **Dog Age Test** — Separate saliva test using DNA methylation to estimate age and birthdate range; original model withdrawn and refunded, revised model relaunched in 2023.
- **Gut Health Test** — AnimalBiome-powered fecal microbiome test with diet, supplement and lifestyle recommendations; US-only shipping.
- **Allergy and Joint Supplements** — Consumer supplements marketed for seasonal itching and mobility support.
- **Embark App** — Consumer access to breed, health, trait and relative results; not compatible with breeder or vet accounts.
- **Allergy Risk Scores** — Genetic estimates for environmental, food, contact and flea allergy risk.
- **Mast Cell Tumor Risk Score** — Cancer risk score extended to all dog breeds in March 2026.

## Achievements

- Reports three million dogs tested on its current milestone page.
- Published a 2018 PLOS Genetics study using 6,000 dogs that identified a duplication near ALX4 associated with blue eyes.
- Raised a US$75 million Series B in July 2021.
- Launched DNA-based allergy risk scores in 2025.
- Extended its mast cell tumor risk score to all breeds in March 2026.

## Latest updates

- **2025-04** — Published an explanation of new genetic allergy risk scores.
- **2025-07** — Cornellians reported more than 2.5 million test samples and continuing research collaboration.
- **2026-03** — Mast cell tumor risk score expanded to all dog breeds, according to the help center.
- **2026-05** — Updated Age Test help article describes a reference dataset of more than 2,000 dogs and reports 77% of birthdays within 12 months of estimates.

## Links

- Website: https://embarkvet.com/
- LinkedIn: https://www.linkedin.com/company/embark-vet/
- Twitter/X: https://twitter.com/embarkvet
- YouTube: https://www.youtube.com/channel/UCv5RSkcC9YEY-wQjfdqHfTQ
- Instagram: https://www.instagram.com/embarkvet/
- Facebook: https://www.facebook.com/EmbarkVet/
- TikTok: https://www.tiktok.com/@embarkvet

---

Profile page: https://yespress.io/embark-veterinary
Published by YesPress — https://yespress.io
Last updated: 2026-10-05